NCT00909753View on ClinicalTrials.gov

Ursodiol 500 mg Tablets Under Fed Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

October 31, 2006

Study Completion Date

October 31, 2006

Conditions
Healthy
Interventions
DRUG

Ursodiol

Ursodiol Tablets, 500 mg

DRUG

Urso Forte™

Urso Forte™ Tablets, 500 mg

Trial Locations (1)

M1R 5A3

Pharma Medica Research Inc., Toronto

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00909753 - Ursodiol 500 mg Tablets Under Fed Conditions | Biotech Hunter | Biotech Hunter